Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

Stock Quote Disclaimer: Copyright © 1998-2002 MarketWatch.com Inc. User agreement applies. Historical and current end-of-day data provided by Interactive Data Corp. Intraday data is at least 20-minutes delayed. All times are EDT. Intraday data provided by S&P Comstock and subject to terms of use.

NYSE | BMY 21.52 | -0.46 | 4:01 PM EDT | 27 Aug 2008

Top Stories

$1.2 Million Grant to Make Access to Mental Health Care Easier for Rural Alabamians The Bristol-Myers Squibb Foundation gives $1.2 million to improve life in Alabama's Black Belt region—a band of counties, largely rural, with high rates of poverty, economic stagnation and inadequate health care.
Read more >>

Latest News
08.26.2008>>Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program 08.19.2008>>Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma 08.13.2008>>NJ, CT, NY & MD School Districts Join Program That Teaches High School Students How Medicines Are Made